Selected research
Industry Growth & Trends
Global AI in Respiratory Diseases Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global AI in Respiratory Diseases market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for AI in Respiratory Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for AI in Respiratory Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI in Respiratory Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the AI in Respiratory Diseases market include ArtiQ, Philips Healthcare, GE Healthcare, Siemens Healthineers, Swaasa AI, THIRONA, DeepMind Health, Verily and VIDA Diagnostics Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global AI in Respiratory Diseases market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The AI in Respiratory Diseases market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AI in Respiratory Diseases market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AI in Respiratory Diseases.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global AI in Respiratory Diseases market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
AI in Respiratory Diseases Market by Company
ArtiQ
Philips Healthcare
GE Healthcare
Siemens Healthineers
Swaasa AI
THIRONA
DeepMind Health
Verily
VIDA Diagnostics Inc
Icometrix
Infervision
PneumoWave
Respiray
Dectrocel Healthcare
Zynnon
AI in Respiratory Diseases Segment by Type
Pulmonary Infection
MRI
CT Scan
AI in Respiratory Diseases Segment by Application
Hospital
Diagnostic Centers
Ambulatory Surgical Centers
Others
AI in Respiratory Diseases Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI in Respiratory Diseases market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI in Respiratory Diseases and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI in Respiratory Diseases.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of AI in Respiratory Diseases companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Pulmonary Infection
- MRI
- CT Scan
Applications
- Hospital
- Diagnostic Centers
- Ambulatory Surgical Centers
- Others
Companies covered
- ArtiQ
- Philips Healthcare
- GE Healthcare
- Siemens Healthineers
- Swaasa AI
- THIRONA
- DeepMind Health
- Verily
- VIDA Diagnostics Inc
- Icometrix
- Infervision
- PneumoWave
- Respiray
- Dectrocel Healthcare
- Zynnon
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global AI in Respiratory Diseases Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global AI in Respiratory Diseases Market Size by Region (2021-2032)
- 1.4.1 Global AI in Respiratory Diseases Market Size by Region (2021-2026)
- 1.4.2 Global AI in Respiratory Diseases Market Size by Region (2027-2032)
- 1.5 Key Regions AI in Respiratory Diseases Market Size (2021-2032)
- 1.5.1 North America AI in Respiratory Diseases Market Size Growth Rate (2021-2032)
- 1.5.2 Europe AI in Respiratory Diseases Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific AI in Respiratory Diseases Market Size Growth Rate (2021-2032)
- 1.5.4 South America AI in Respiratory Diseases Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa AI in Respiratory Diseases Market Size Growth Rate (2021-2032)
2 AI in Respiratory Diseases Market by Type
- 2.1 Type Introduction
- 2.1.1 Pulmonary Infection
- 2.1.2 MRI
- 2.1.3 CT Scan
- 2.2 Global AI in Respiratory Diseases Market Size by Type
- 2.2.1 Global AI in Respiratory Diseases Market Size Overview by Type (2021-2032)
- 2.2.2 Global AI in Respiratory Diseases Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global AI in Respiratory Diseases Market Size Forecasted by Type (2027-2032)
- 2.3 Global AI in Respiratory Diseases Market Size by Regions
- 2.3.1 North America AI in Respiratory Diseases Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe AI in Respiratory Diseases Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific AI in Respiratory Diseases Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America AI in Respiratory Diseases Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa AI in Respiratory Diseases Market Size Breakdown by Type (2021-2026)
3 AI in Respiratory Diseases Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Diagnostic Centers
- 3.1.3 Ambulatory Surgical Centers
- 3.1.4 Others
- 3.2 Global AI in Respiratory Diseases Market Size by Application
- 3.2.1 Global AI in Respiratory Diseases Market Size Overview by Application (2021-2032)
- 3.2.2 Global AI in Respiratory Diseases Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global AI in Respiratory Diseases Market Size Forecasted by Application (2027-2032)
- 3.3 Global AI in Respiratory Diseases Market Size by Regions
- 3.3.1 North America AI in Respiratory Diseases Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe AI in Respiratory Diseases Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific AI in Respiratory Diseases Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America AI in Respiratory Diseases Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa AI in Respiratory Diseases Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 AI in Respiratory Diseases Industry Trends
- 4.2 AI in Respiratory Diseases Industry Drivers
- 4.3 AI in Respiratory Diseases Industry Opportunities and Challenges
- 4.4 AI in Respiratory Diseases Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by AI in Respiratory Diseases Revenue (2021-2026)
- 5.2 Global AI in Respiratory Diseases Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global AI in Respiratory Diseases Key Company Headquarters & Area Served
- 5.4 Global AI in Respiratory Diseases Company, Product Type & Application
- 5.5 Global AI in Respiratory Diseases Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global AI in Respiratory Diseases Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 AI in Respiratory Diseases Players Market Share by Revenue in 2025
- 5.6.3 2025 AI in Respiratory Diseases Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 ArtiQ
- 6.1.1 ArtiQ Company Information
- 6.1.2 ArtiQ Business Overview
- 6.1.3 ArtiQ AI in Respiratory Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 ArtiQ AI in Respiratory Diseases Product Portfolio
- 6.1.5 ArtiQ Recent Developments
- 6.2 Philips Healthcare
- 6.2.1 Philips Healthcare Company Information
- 6.2.2 Philips Healthcare Business Overview
- 6.2.3 Philips Healthcare AI in Respiratory Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Philips Healthcare AI in Respiratory Diseases Product Portfolio
- 6.2.5 Philips Healthcare Recent Developments
- 6.3 GE Healthcare
- 6.3.1 GE Healthcare Company Information
- 6.3.2 GE Healthcare Business Overview
- 6.3.3 GE Healthcare AI in Respiratory Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 GE Healthcare AI in Respiratory Diseases Product Portfolio
- 6.3.5 GE Healthcare Recent Developments
- 6.4 Siemens Healthineers
- 6.4.1 Siemens Healthineers Company Information
- 6.4.2 Siemens Healthineers Business Overview
- 6.4.3 Siemens Healthineers AI in Respiratory Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Siemens Healthineers AI in Respiratory Diseases Product Portfolio
- 6.4.5 Siemens Healthineers Recent Developments
- 6.5 Swaasa AI
- 6.5.1 Swaasa AI Company Information
- 6.5.2 Swaasa AI Business Overview
- 6.5.3 Swaasa AI AI in Respiratory Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Swaasa AI AI in Respiratory Diseases Product Portfolio
- 6.5.5 Swaasa AI Recent Developments
- 6.6 THIRONA
- 6.6.1 THIRONA Company Information
- 6.6.2 THIRONA Business Overview
- 6.6.3 THIRONA AI in Respiratory Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 THIRONA AI in Respiratory Diseases Product Portfolio
- 6.6.5 THIRONA Recent Developments
- 6.7 DeepMind Health
- 6.7.1 DeepMind Health Company Information
- 6.7.2 DeepMind Health Business Overview
- 6.7.3 DeepMind Health AI in Respiratory Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 DeepMind Health AI in Respiratory Diseases Product Portfolio
- 6.7.5 DeepMind Health Recent Developments
- 6.8 Verily
- 6.8.1 Verily Company Information
- 6.8.2 Verily Business Overview
- 6.8.3 Verily AI in Respiratory Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Verily AI in Respiratory Diseases Product Portfolio
- 6.8.5 Verily Recent Developments
- 6.9 VIDA Diagnostics Inc
- 6.9.1 VIDA Diagnostics Inc Company Information
- 6.9.2 VIDA Diagnostics Inc Business Overview
- 6.9.3 VIDA Diagnostics Inc AI in Respiratory Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 VIDA Diagnostics Inc AI in Respiratory Diseases Product Portfolio
- 6.9.5 VIDA Diagnostics Inc Recent Developments
- 6.10 Icometrix
- 6.10.1 Icometrix Company Information
- 6.10.2 Icometrix Business Overview
- 6.10.3 Icometrix AI in Respiratory Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Icometrix AI in Respiratory Diseases Product Portfolio
- 6.10.5 Icometrix Recent Developments
- 6.11 Infervision
- 6.11.1 Infervision Company Information
- 6.11.2 Infervision Business Overview
- 6.11.3 Infervision AI in Respiratory Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Infervision AI in Respiratory Diseases Product Portfolio
- 6.11.5 Infervision Recent Developments
- 6.12 PneumoWave
- 6.12.1 PneumoWave Company Information
- 6.12.2 PneumoWave Business Overview
- 6.12.3 PneumoWave AI in Respiratory Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 PneumoWave AI in Respiratory Diseases Product Portfolio
- 6.12.5 PneumoWave Recent Developments
- 6.13 Respiray
- 6.13.1 Respiray Company Information
- 6.13.2 Respiray Business Overview
- 6.13.3 Respiray AI in Respiratory Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Respiray AI in Respiratory Diseases Product Portfolio
- 6.13.5 Respiray Recent Developments
- 6.14 Dectrocel Healthcare
- 6.14.1 Dectrocel Healthcare Company Information
- 6.14.2 Dectrocel Healthcare Business Overview
- 6.14.3 Dectrocel Healthcare AI in Respiratory Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Dectrocel Healthcare AI in Respiratory Diseases Product Portfolio
- 6.14.5 Dectrocel Healthcare Recent Developments
- 6.15 Zynnon
- 6.15.1 Zynnon Company Information
- 6.15.2 Zynnon Business Overview
- 6.15.3 Zynnon AI in Respiratory Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Zynnon AI in Respiratory Diseases Product Portfolio
- 6.15.5 Zynnon Recent Developments
7 North America
- 7.1 North America AI in Respiratory Diseases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America AI in Respiratory Diseases Market Size by Country (2021-2026)
- 7.3 North America AI in Respiratory Diseases Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe AI in Respiratory Diseases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe AI in Respiratory Diseases Market Size by Country (2021-2026)
- 8.3 Europe AI in Respiratory Diseases Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific AI in Respiratory Diseases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific AI in Respiratory Diseases Market Size by Country (2021-2026)
- 9.3 Asia-Pacific AI in Respiratory Diseases Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America AI in Respiratory Diseases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America AI in Respiratory Diseases Market Size by Country (2021-2026)
- 10.3 South America AI in Respiratory Diseases Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa AI in Respiratory Diseases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa AI in Respiratory Diseases Market Size by Country (2021-2026)
- 11.3 Middle East & Africa AI in Respiratory Diseases Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst